Inclusion Criteria:  BMI 25-40 kg/m2 ≥ 1 criterion for metabolic syndrome (i.e., waist circumference ≥ 94 cm men or ≥ 80 cm women; triglycerides ≥150 mg/dL; HDL-cholesterol ≤ 40 mg/dL men or ≤ 50 mg/dL women; systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg; fasting plasma glucose ≥100 mg/dL) at screening  Exclusion Criteria:  Current use of tobacco-containing products or (≤6 months) cessation Allergy/sensitivity/intolerance/dislike of study foods Women who are pregnant, lactating, planning to become pregnant or have given birth in the past year Individuals who have had a cardiovascular event (heart attack, revascularization, stroke), or have a history of heart failure, liver, kidney, autoimmune diseases or inflammatory conditions such as gastrointestinal disorders or rheumatoid arthritis. Type 1 or type 2 diabetes Unstable weight ≥10% body weight for 6 months prior to enrollment Systolic Blood pressure >160 mmHg for systolic pressure and/or diastolic blood pressure >/100 mmHg for diastolic pressure at screening Fasting blood glucose ≥126 mg/dL at screening Triglycerides ≥350 mg/dL at screening Taking any medications known to affect lipids, blood pressure, or blood glucose levels Diagnosed inflammatory conditions or taking prescribed , taking any chronic anti-inflammatory medications (>1 time per week over the past 3 months) Use of antibiotics within the prior 8 weeks Taking supplements (e.g., psyllium, fish oil, soy lecithin, and phytoestrogens) and botanicals known to affect study outcomes and not willing to cease for the duration of the study Individuals consuming >14 alcoholic drinks/week, and not willing to avoid alcohol consumption for 48 hours prior to test visit Pre-menopausal women who do not have a regular menstrual cycle of 25-35 days PI discretion